Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past hour
    • Any time
    • Past 24 hours
    • Past 7 days
    • Past 30 days
32m

Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in ...

Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Walmart CEO to retire
Sues to block CA House map
Rubiales egged by uncle
Families sue ByHeart
Clase pleads not guilty
Nevada ‘fake electors’ case
Alligator rescued in Boston
Some agents to get bonuses
US, Argentina trade deal
Launches NASA spacecraft
Under Armour splits w/ Curry
Linked to cancer risk?
Day care teacher released
Jim Avila dies
SoCal evacuation warnings
Trump pardons Joe Lewis
John Fetterman hospitalized
US conducts 20th strike
Union workers go on strike
Colorado AD to step down
Raises 401(k), IRA limits
Governor grants clemency
Judge denies McIver’s bid
Win NL, AL MVP awards
MLS calendar to change
Pack Fire in Mono County
Defense workers end strike
Trans members sue admin
Padres could be up for sale?
To cut about 15,000 jobs?
Feedback
  • Privacy
  • Terms